| Title |
Metronomic cyclophosphamide regimen selectively depletes CD4+CD25+ regulatory T cells and restores T and NK effector functions in end stage cancer patients
|
|---|---|
| Published in |
Cancer Immunology, Immunotherapy, September 2006
|
| DOI | 10.1007/s00262-006-0225-8 |
| Pubmed ID | |
| Authors |
François Ghiringhelli, Cedric Menard, Pierre Emmanuel Puig, Sylvain Ladoire, Stephan Roux, François Martin, Eric Solary, Axel Le Cesne, Laurence Zitvogel, Bruno Chauffert |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 1 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 374 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| France | 3 | <1% |
| United States | 2 | <1% |
| Mexico | 1 | <1% |
| Belgium | 1 | <1% |
| Unknown | 367 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 83 | 22% |
| Researcher | 80 | 21% |
| Student > Bachelor | 35 | 9% |
| Student > Master | 30 | 8% |
| Other | 19 | 5% |
| Other | 64 | 17% |
| Unknown | 63 | 17% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 93 | 25% |
| Agricultural and Biological Sciences | 65 | 17% |
| Immunology and Microbiology | 44 | 12% |
| Biochemistry, Genetics and Molecular Biology | 40 | 11% |
| Pharmacology, Toxicology and Pharmaceutical Science | 19 | 5% |
| Other | 29 | 8% |
| Unknown | 84 | 22% |
Attention Score in Context
This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 26 March 2024.
All research outputs
#5,393,063
of 25,837,817 outputs
Outputs from Cancer Immunology, Immunotherapy
#550
of 3,008 outputs
Outputs of similar age
#15,904
of 90,629 outputs
Outputs of similar age from Cancer Immunology, Immunotherapy
#4
of 20 outputs
Altmetric has tracked 25,837,817 research outputs across all sources so far. Compared to these this one has done well and is in the 79th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,008 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.5. This one has done well, scoring higher than 81% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 90,629 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 83% of its contemporaries.
We're also able to compare this research output to 20 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 80% of its contemporaries.